Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A Brian Markison


  • Director at Lantheus Holdings Inc. (LNTH), 2019-07-12
  • Chief Executive Officer at Osmotica Pharmaceuticals Plc (OSMT), 2019-02-27
  • at Organogenesis Holdings Inc. (ORGO), 2018-12-13
  • Director at Immunomedics Inc (IMMU), 2017-11-21
  • Director at Alere Inc. (ALR), 2017-10-03
  • Director at Pharmathene Inc (PIP), 2015-01-06
  • President And Ceo at King Pharmaceuticals Inc (KG), 2011-03-01
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LNTH $28.07 4,918 Director 27,549 2019-07-10 Filing
LNTH $28.41 5,000 Director 32,467 2019-07-03 Filing
LNTH $27.67 5,000 Director 37,467 2019-06-26 Filing
LNTH $27.40 5,000 Director 42,467 2019-06-19 Filing
LNTH $25.27 5,000 Director 47,467 2019-06-12 Filing